Clinical Trial 40104

share

Upland, CA 91786


Study Summary:

A randomized, double-blind, parallel-group, multicenter study of secukinumab to commpare 300 mg and 150 mg at week 52 in patients with Ankylosing Spondylitis who are randomized to dose escalation after not achiving inactive disease during an initial 16 weeks of open-label treatment with secukinumab 150 mg ( ASLeap )


Qualified Participants May Receive:

Free treatment, Doctor visits, Laboratory results, Compensation of $40.00 per visit completed if patient qualifies.


Study is Available At:

Inland Rheumatology Clinical Trials, Inc
1238 E. Arrow Hwy
Upland, CA 91786
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.